Digital health: trends, opportunities and challenges in medical devices, pharma and bio-technology

N Kasoju, NS Remya, R Sasi, S Sujesh, B Soman… - CSI Transactions on …, 2023 - Springer
Digital health interventions refer to the use of digital technology and connected devices to
improve health outcomes and healthcare delivery. This includes telemedicine, electronic …

In silico Approaches for the Design and Optimization of Interfering Peptides Against Protein–Protein Interactions

ZS Hashemi, M Zarei, MK Fath, M Ganji… - Frontiers in Molecular …, 2021 - frontiersin.org
Large contact surfaces of protein–protein interactions (PPIs) remain to be an ongoing issue
in the discovery and design of small molecule modulators. Peptides are intrinsically capable …

Assessing the potential of NS2B/NS3 protease inhibitors biomarker in curbing dengue virus infections: In silico vs. In vitro approach

H Norshidah, CH Leow, KE Ezleen… - Frontiers in cellular …, 2023 - frontiersin.org
An increase in the occurrence of viral infectious diseases is a global concern for human
health. According to a WHO report, dengue virus (DENV) is one of the most common viral …

Fragment tailoring strategy to design novel chemical entities as potential binders of novel corona virus main protease

C Choudhury - Journal of Biomolecular Structure and Dynamics, 2021 - Taylor & Francis
The recent pandemic of severe acute respiratory syndrome–coronavirus2 (SARS-CoV-2)
infection (COVID-19) has put the world on serious alert. The main protease of SARS-CoV-2 …

[HTML][HTML] Graphormerdti: a graph transformer-based approach for drug-target interaction prediction

M Gao, D Zhang, Y Chen, Y Zhang, Z Wang… - Computers in Biology …, 2024 - Elsevier
Abstract The application of Artificial Intelligence (AI) to screen drug molecules with potential
therapeutic effects has revolutionized the drug discovery process, with significantly lower …

Therapeutic targets and computational approaches on drug development for COVID-19

A Shanmugam, N Muralidharan… - Current Topics in …, 2020 - ingentaconnect.com
World Health Organization declared coronavirus disease (COVID-19) caused by SARS
coronavirus-2 (SARS-CoV-2) as pandemic. Its outbreak started in China in Dec 2019 and …

Chagas disease: drug development and parasite targets

AB Vermelho, V Cardoso, FRP Mansoldo… - … Drug Development and …, 2022 - Springer
Chagas disease (CD) is a neglected disease that is endemic to Central and South America
and is caused by the protozoan parasite Trypanosoma cruzi. The discovery of new drugs …

Fragment-based Drug Discovery Strategy and its Application to the Design of SARS-CoV-2 Main Protease Inhibitor

Y Jiang, Y Wu, J Wang, Y Ma, H Yu… - Current Medicinal …, 2024 - benthamdirect.com
Severe Acute Respiratory Syndrome Coronavirus Type 2 (SARS-CoV-2) emerged at the end
of 2019, causing a highly infectious and pathogenic disease known as 2019 coronavirus …

Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy

AA Mori, LR de Castro, RH Bortolin, GM Bastos… - Forensic Science …, 2021 - Elsevier
Hypertrophic cardiomyopathy (HCM) is characterized by unexplained left ventricular
hypertrophy (LVH) and is one of the major causes of sudden cardiac death (SCD). An exon …

[HTML][HTML] Peptide Inhibitor Assay for Allocating Functionally Important Accessible Sites Throughout a Protein Chain: Restriction Endonuclease EcoRI as a Model Protein …

JM Otaki - BioTech, 2024 - mdpi.com
Functionally important amino acid sequences in proteins are often located at multiple sites.
Three-dimensional structural analysis and site-directed mutagenesis may be performed to …